Friday 6 November 2026 Export SNY’s income statement to Excel — free account

Sanofi

SNY Healthcare Drug Manufacturers General

Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024.

Revenue: +13.9%
EPS: +8.21%
Free cash flow: +99.6%
Total debt: −11.2%

Quarter to September 2026, against a year earlier

Dividend growth 3 yrs

46.21 0.70 −1.49%

Follow SNY

Alert me

Market cap: $111.8B
P/E: 23.2×
Fwd P/E: —
Dividend yield: 5.18%
F-score: 7/9
Altman Z: 2.50
Beneish M: −2.63
Dividend safety: 54/100

Overview

Sanofi (SNY) Current ratio

Alert me on Current ratio

Sanofi's current ratio at the end of the quarter to 30 September 2026 was 1.1×, up 0.0× from fiscal 2025 (1.1×). Over the past ten years it has ranged from 1.1× (fiscal 2025) to 1.8× (fiscal 2020) — the current reading is the lowest in ten years. That is below the Drug Manufacturers General industry median of 1.4× and below the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/SNY/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Sanofi current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/SNY/metrics/current-ratio">Sanofi (SNY) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	1.1×	(25.23%)
FY2024	1.5×	15.20%
FY2023	1.3×	(10.72%)
FY2022	1.4×	(1.07%)
FY2021	1.4×	(18.03%)
FY2020	1.8×	24.73%
FY2019	1.4×	(0.76%)
FY2018	1.4×	(17.03%)
FY2017	1.7×	4.99%
FY2016	1.6×	9.60%

Period	Current ratio	Change
Sep 2026	1.1×	13.01%
Jun 2026	1.0×	(1.79%)
Mar 2026	1.0×	(7.95%)
Dec 2025	1.1×	2.99%
21 more quarters	Free account

Against its own ten years

Low 1.1× High 1.8×

Ten-year median 1.4×

Current reading's percentile 9

Company	Current ratio
BMY Bristol Myers Squibb Company compare	1.6×
AMGN Amgen Inc. compare	1.5×
PFE Pfizer Inc. compare	1.4×
GILD Gilead Sciences, Inc. compare	1.4×
SNY Sanofi	1.1×
AZN AstraZeneca PLC compare	1.0×
NVS Novartis AG compare	0.9×
NVO Novo Nordisk A/S compare	0.9×
GSK GSK PLC Sponsored ADR compare	0.9×
Drug Manufacturers General industry median	1.4×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

Sanofi (SNY) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on SNY

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on SNY

Stockrow Weekly